Emulation of the KEYNOTE-189 Trial Using Electronic Health Records

计划入组 1,854 人 · 首次发布于 2023 年 6 月 18 日

Pembrolizumab in Advanced Solid Tumors Analyzed for Predictive Biomarkers (KEYNOTE 158)

计划入组 2 人

CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3]

计划入组 851 人 · 首次发布于 2024 年 9 月 23 日

Keyhole limpet hemocyanin

Keyhole limpet haemocyanin(Intracel Corp.)

heroin-like hapten + keyhole limpet hemocyanin vaccine

Kenota Inc.

Canada

Merck Discontinues Phase 3 Trials of Pembrolizumab in NSCLC and CSCC

KEYNOTE-789: Pembrolizumab Plus Chemotherapy Fails to Improve Survival in EGFR-Mutated NSCLC

Pembrolizumab Plus Chemotherapy Improves Overall Survival in HER2-Positive Gastric Cancer